Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A pregnant woman with pancytopenia.

Jensvoll H, Smeland MF, Tiller H, Holla ØL, Prescott TE, Vik A.

Tidsskr Nor Laegeforen. 2019 Nov 18;139(17). doi: 10.4045/tidsskr.19.0022. Print 2019 Nov 19. Norwegian, English. No abstract available.

2.

Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort.

Blix K, Gran OV, Severinsen MT, Cannegieter SC, Jensvoll H, Overvad K, Hammerstrøm J, Tjønneland A, Naess IA, Braekkan SK, Rosendaal FR, Kristensen SR, Hansen JB.

J Thromb Haemost. 2018 Jul;16(7):1327-1335. doi: 10.1111/jth.14130. Epub 2018 May 27.

PMID:
29691978
3.

Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.

Gade IL, Brækkan S, Næss IA, Hansen JB, Rosendaal F, Cannegieter S, Overvad K, Jensvoll H, Hammerstrøm J, Gran OV, Tjønneland A, Kristensen SR, Severinsen MT.

Thromb Res. 2017 Oct;158:157-160. doi: 10.1016/j.thromres.2017.09.002. Epub 2017 Sep 5.

PMID:
28926801
4.

The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort.

Gade IL, Braekkan SK, Naess IA, Hansen JB, Cannegieter SC, Overvad K, Jensvoll H, Hammerstrøm J, Blix K, Tjønneland A, Kristensen SR, Severinsen MT.

J Thromb Haemost. 2017 Aug;15(8):1567-1575. doi: 10.1111/jth.13752. Epub 2017 Jul 11.

5.

A novel ANKRD26 gene variant causing inherited thrombocytopenia in a family of Finnish origin: Another brick in the wall?

Averina M, Jensvoll H, Strand H, Sovershaev M.

Thromb Res. 2017 Mar;151:41-43. doi: 10.1016/j.thromres.2017.01.001. Epub 2017 Jan 10. No abstract available.

PMID:
28109976
6.

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.

Gran OV, Smith EN, Brækkan SK, Jensvoll H, Solomon T, Hindberg K, Wilsgaard T, Rosendaal FR, Frazer KA, Hansen JB.

Haematologica. 2016 Sep;101(9):1046-53. doi: 10.3324/haematol.2016.147405. Epub 2016 Jun 16.

7.

Existing data sources in clinical epidemiology: the Scandinavian Thrombosis and Cancer Cohort.

Jensvoll H, Severinsen MT, Hammerstrøm J, Brækkan SK, Kristensen SR, Cannegieter SC, Blix K, Tjønneland A, Rosendaal FR, Dziewiecka O, Overvad K, Næss IA, Hansen JB.

Clin Epidemiol. 2015 Sep 16;7:401-10. doi: 10.2147/CLEP.S84279. eCollection 2015.

8.

Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.

Jensvoll H, Blix K, Brækkan SK, Hansen JB.

PLoS One. 2014 Mar 18;9(3):e92011. doi: 10.1371/journal.pone.0092011. eCollection 2014.

9.

White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.

Blix K, Jensvoll H, Brækkan SK, Hansen JB.

PLoS One. 2013 Sep 4;8(9):e73447. doi: 10.1371/journal.pone.0073447. eCollection 2013.

Supplemental Content

Loading ...
Support Center